Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

Conditions: mCRPC (Metastatic Castration-resistant Prostate Cancer); Genital Diseases, Male; Urogenital Diseases, Male; Prostatic Disease; Prostatic Neoplasms, Castration-Resistant; Prostate Cancer Interventions: Drug: Gedatolisib; Drug: Darolutamide Sponsors: Celcuity Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials